Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved
This is the 2015 version of HCPCS G9077 - please refer to the 2016 HCPCS code set for the latest version.
Added on Sunday, January 01, 2006
Status changed on Monday, January 01, 2007 to: No maintenance for this code
